Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | AGAR T cells |
Synonyms | |
Therapy Description |
Limited information is currently available on AGAR T cells, a putative GPC3 CAR T cell carrying an inducible Caspase 9 (iC9) and IL15 (Apr 2023). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
AGAR T cells | Limited information is currently available on AGAR T cells, a putative GPC3 CAR T cell carrying an inducible Caspase 9 (iC9) and IL15 (Apr 2023). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT04377932 | Phase I | Cyclophosphamide + Fludarabine AGAR T cells | Interleukin-15 Armored Glypican 3-specific Chimeric Antigen Receptor Expressed in T Cells for Pediatric Solid Tumors | Recruiting | USA | 0 |